Related Experiment Video
Updated: May 20, 2026
Obtaining Human Microglia from Adult Human Brain Tissue
Published on: August 30, 2020
Microglia in Alzheimer's Disease: It's All About Context
1Regenerative Medicine Institute Neural Program and Department of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Steven Spielberg Building Room 345, Los Angeles, CA 90048, USA.
Abstract:
Neuroinflammation is now regarded as both an early event and prime mover in the pathobiology of Alzheimer disease (AD), a neurodegenerative disease that represents a growing public health threat. As the resident innate immune cells within the central nervous system, microglia are centrally positioned as key orchestrators of brain inflammation. It is now accepted that numerous forms of activated microglia exist. Furthermore, while some types of reactive microglia are detrimental, others can actually be beneficial. In the context of AD etiopathology, much debate surrounds whether these enigmatic cells play "good" or "bad" roles. In this article, we distill a complex clinical and experimental literature focused on the contribution of microglia to AD pathology and progression. A synthesis of the literature only seems possible when considering context- the conditions under which microglia encounter and mount immunological responses to AD pathology. In order to carry out these diverse contextual responses, a number of key receptors and signaling pathways are variously activated. It will be critically important for future studies to address molecular mediators that lead to beneficial microglial responses and therefore represent important therapeutic targets for AD.
Insights
Microglia, the brain's immune cells, play complex roles in Alzheimer disease (AD). Understanding their context-dependent "good" or "bad" functions is key to developing new AD therapies.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Neuroinflammation is an early and critical factor in Alzheimer disease (AD) pathogenesis.
- Microglia, the central nervous system's innate immune cells, are central to brain inflammation in AD.
- The precise role of microglia in AD, whether beneficial or detrimental, remains a subject of debate.
Purpose of the Study:
- To synthesize the complex literature on microglial contributions to Alzheimer disease pathology and progression.
- To explore the dual nature of microglial responses in the context of AD.
- To identify potential therapeutic targets by understanding beneficial microglial functions.
Main Methods:
- Review and synthesis of existing clinical and experimental literature on microglia and AD.
- Analysis of the contextual factors influencing microglial responses to AD pathology.
- Identification of key receptors and signaling pathways involved in microglial activation.
Main Results:
- Microglial roles in AD are context-dependent, with both detrimental and beneficial functions observed.
- Diverse forms of activated microglia exist, responding differently to AD-related stimuli.
- Specific conditions dictate whether microglia exacerbate or ameliorate AD pathology.
Conclusions:
- A contextual understanding of microglial behavior is essential for resolving their role in AD.
- Targeting molecular mediators of beneficial microglial responses presents a promising therapeutic avenue for AD.
- Future research should focus on elucidating these mediators for effective AD treatment strategies.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
01:22Alzheimer's Disease: Treatment